T-bet deficiency facilitates airway colonization by Mycoplasma pulmonis in a murine model of asthma

Journal of Immunology

Volumn 177, Issue 3, 2006, Pages 1786-1795

  Bakshi, Chandra Shekhar ^a   Malik, Meenakshi ^a   Carrico, Pauline M ^b   Sellati, Timothy J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b Fission Communications   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE MODEL; EOSINOPHILIA; EPIDEMIOLOGICAL DATA; GENETIC PREDISPOSITION; MOUSE; MYCOPLASMA PULMONIS; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RESPIRATORY TRACT INFECTION; SYMPTOMATOLOGY; T BET DEFICIENCY; TH2 CELL;

EID: 33746215188     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.3.1786     Document Type: Article

References (58)

1. Weinberger, M. 2004. Respiratory infections and asthma: current treatment strategies. Drug Discov. Today 9: 831-837.
2. Freymuth, F., A. Vabret, J. Brouard, F. Toutain, R. Verdon, J. Petitjean, S. Gouarin, J. F. Duhamel, and B. Guillois. 1999. Detection of viral. Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J. Clin. Virol. 13: 131-139.
3. Seggev, J. S., I. Lis, R. Siman-Tov, R. Gutman, H. Abu-Samara, G. Schey, and Y. Naot. 1986. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann. Allergy 57: 263-265.
4. Kraft, M., G. H. Cassell, J. E. Henson, H. Watson, J. Williamson, B. P. Marmion, C. A. Gaydos, and R. J. Martin. 1998. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am. J. Respir. Crit. Care Med. 158: 998-1001.
5. Martin, R. J., M. Kraft, H. W. Chu, E. A. Berns, and G. H. Cassell. 2001. A link between chronic asthma and chronic infection. J. Allergy Clin. Immunol. 107: 595-601.
6. Cassell, G. H. 1982. The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model. Rev. Infect. Dis. 4(Suppl.): S18-S34.
7. Clyde, W. A., Jr. 1983. Mycoplasma pneumoniae respiratory disease symposium: summation and significance. Yale J. Biol. Med. 56: 523-527.
8. Biscardi, S., M. Lorrot, E. Marc, F. Moulin, B. Boutonnat-Faucher, C. Heilbronner, J. L. Iniguez, M. Chaussain, E. Nicand, J. Raymond, and D. Gendrel. 2004. Mycoplasma pneumoniae and asthma in children. Clin. Infect. Dis. 38: 1341-1346.
9. Davis, J. K., M. K. Davidson, T. R. Schoeb, and J. R. Lindsey. 1992. Decreased intrapulmonary killing of Mycoplasma pulmonis after short-term exposure to NO2 is associated with damaged alveolar macrophages. Am. Rev. Respir. Dis. 145: 406-411.
10. + Th cell-associated inflammatory lesions during murine mycoplasma respiratory disease. J. Immunol. 168: 3493-3501.
11. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259: 1739-1742.
12. Moncada, S., and E. A. Higgs. 1991. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J. Clin. Invest. 21: 361-374.
13. Li, L., Y. Xia, A. Nguyen, L. Feng, and D. Lo. 1998. Th2-induced eotaxin expression and eosinophilia coexist with Th1 responses at the effector stage of lung inflammation. J. Immunol. 161: 3128-3135.
14. Randolph, D. A., C. J. Carruthers, S. J. Szabo, K. M. Murphy, and D. D. Chaplin. 1999. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J. Immunol. 162: 2375-2383.
15. Finotto, S., M. F. Neurath, J. N. Glickman, S. Qin, H. A. Lehr, F. H. Green, K. Ackerman, K. Haley, P. R. Galle, S. J. Szabo, et al. 2002. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295: 336-338.
16. Finotto, S., M. Hausding, A. Doganci, J. H. Maxeiner, H. A. Lehr, C. Luft, P. R. Galle, and L. H. Glimcher. 2005. Asthmatic changes in mice lacking T-bet are mediated by IL-13. Int. Immunol. 17: 993-1007.
17. Szabo, S. J., B. M. Sullivan, C. Stemmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295: 338-342.
18. Ravindran, R., J. Foley, T. Stoklasek, L. H. Glimcher, and S. J. McSorley. 2005. Expression of T-bet by CD4 T cells is essential for resistance to Salmonella infection. J. Immunol. 175: 4603-4610.
19. Sullivan, B. M., O. Jobe, V. Lazarevic, K. Vasquez, R. Bronson, L. H. Glimcher, and I. Kramnik. 2005. Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFN-γ production. J. Immunol. 175: 4593-4602.
20. Hultgren, O. H., M. Verdrengh, and A. Tarkowski. 2004. T-box transcription-factor-deficient mice display increased joint pathology and failure of infection control during staphylococcal arthritis. Microbes Infect. 6: 529-535.
21. Gaga, M., P. Lambrou, N. Papageorgiou, N. G. Koulouris, E. Kosmas, S. Fragakis, C. Sofios, A. Rasidakis, and J. Jordanoglou. 2000. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin. Exp. Allergy 30: 663-669.
22. Feelisch, M., T. Rassaf, S. Mnaimneh, N. Singh, N. S. Bryan, D. Jourd'Heuil, and M. Kelm. 2002. Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo. FASEB J. 16: 1775-1785.
23. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156: 766-775.
24. Cartner, S. C., J. W. Simecka, D. E. Briles, G. H. Cassell, and J. R. Lindsey. 1996. Resistance to mycoplasmal lung disease in mice is a complex genetic trait. Infect. Immun. 64: 5326-5331.
25. Hardy, R. D., H. S. Jafri, K. Olsen, M. Wordemann, J. Hatfield, B. B. Rogers, P. Patel, L. Duffy, G. Cassell, G. H. McCracken, and O. Ramilo. 2001. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile. Infect. Immun. 69: 3869-3876.
26. Hardy, R. D., H. S. Jafri, K. Olsen, J. Hatfield, J. Iglehart, B. B. Rogers, P. Patel, G. Cassell, G. H. McCracken, and O. Ramilo. 2002. Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease. Infect. Immun. 70: 649-654.
27. Cassell, G. H., G. Gambill, and L. Duffy. 1996. ELISA in Respiratory Infections of Humans. Academic Press, San Diego.
28. Gil, J. C., R. L. Cedillo, B. G. Mayagoitia, and M. D. Paz. 1993. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann. Allergy. 70: 23-25.
29. Martin, R. J., H. W. Chu, J. M. Honour, and R. J. Harbeck. 2001. Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am. J. Respir. Cell Mol. Biol. 24: 577-582.
30. Kraft, M., G. H. Cassell, J. Pak, and R. J. Martin. 2002. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 121: . 1782-1788.
31. Lugo-Villarino, G., R. Maldonado-Lopez, R. Possemato, C. Penaranda, and L. H. Glimcher. 2003. T-bet is required for optimal production of IFN-γ and antigen-specific T cell activation by dendritic cells. Proc. Natl Acad. Sci. USA 100: 7749-7754.
32. Woolard, M. D., L. M. Hodge, H. P. Jones, T. R. Schoeb, and J. W. Simecka. 2004. The upper and lower respiratory tracts differ in their requirement of IFN-γ and IL-4 in controlling respiratory mycoplasma infection and disease. J. Immunol. 172: 6875-6883.
33. Hickman-Davis, J., J. Gibbs-Erwin, J. R. Lindsey, and S. Matalon. 1999. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite. Proc. Natl. Acad. Sci. USA 96: 4953-4958.
34. Levesque, M. C., M. A. Misukonis, C. W. O'Loughlin, Y. Chen, B. E. Beasley, D. L. Wilson, D. J. Adams, R. Silber, and J. B. Weinberg. 2003. IL-4 and interferon γ regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells. Leukemia 17: 442-450.
35. Guo, F. H., K. Uetani, S. J. Haque, B. R. Williams, R. A. Dweik, F. B. Thunnissen, W. Calhoun, and S. C. Erzurum. 1997. Interferon γ and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J. Clin. Invest. 100: 829-838.
36. Llovera, M., J. D. Pearson, C. Moreno, and V. Riveros-Moreno. 2001. Impaired response to interferon-γ in activated macrophages due to tyrosine nitration of STAT1 by endogenous nitric oxide. Br. J. Pharmacol. 132: 419-426.
37. Wang, C. H., and H. P. Kuo. 2001. Nitric oxide modulates interleukin-1/3 and tumour necrosis factor-α synthesis, and disease regression by alveolar macrophages in pulmonary tuberculosis. Respirology 6: 79-84.
38. Fierro, I. M., V. Nascimento-DaSilva, M. A. Arruda, M. S. Freitas, M. C. Plotkowski, F. Q. Cunha, and C. Barja-Fidalgo. 1999. Induction of NOS in rat blood PMN in vivo and in vitro: modulation by tyrosine kinase and involvement in bactericidal activity. J. Leukocyte Biol. 65: 508-514.
39. Hickman-Davis, J. M., S. M. Michalek, J. Gibbs-Erwin, and J. R. Lindsey. 1997. Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice. Infect. Immun. 65: 2278-2282.
40. Karupiah, G., J. H. Chen, C. F. Nathan, S. Mahalingam, and J. D. MacMicking. 1998. Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection. J. Virol. 72: 7703-7706.
41. Reiss, C. S., and T. Komatsu. 1998. Does nitric oxide play a critical role in viral infections? J. Virol. 72: 4547-4551.
42. Koh, Y. Y., Y. Park, H. J. Lee, and C. K. Kim. 2001. Levels of interleukin-2, interferon-γ, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production. Pediatrics 107: E39.
43. Tang, M. L., J. Coleman, and A. S. Kemp. 1995. Interleukin-4 and interferon-γ production in atopic and non-atopic children with asthma. Clin. Exp. Allergy 25: 515-521.
44. Woolard, M. D., R. D. Hardy, and J. W. Simecka. 2004. IL-4-independent pathways exacerbate methacholine-induced airway hyperreactivity iduring mycoplasma respiratory disease. J. Allergy Clin. Immunol. 114: 645-649.
45. + T-cell trafficking. Blood 106: 3432-3439.
46. Peng, S. L., S. J. Szabo, and L. H. Glimcher. 2002. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl. Acad. Sci. USA 99: 5545-5550.
47. Mehlhop, P. D., M. van de Rijn, A. B. Goldberg, J. P. Brewer, V. P. Kurup, T. R. Martin, and H. C. Oettgen. 1997. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc. Natl. Acad. Sci. USA 94: 1344-1349.
48. Oshiba, A., E. Hamelmann, K. Takeda, K. L. Bradley, J. E. Loader, G. L. Larsen, and E. W. Gelfand. 1996. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (Ig) E and IgG1 in mice. J. Clin. Invest. 97: 1398-1408.
49. Macedo-Soares, M. F., D. M. Itami, C. Lima, A. Perini, E. L. Faquim-Mauro, M. A. Martins, and M. S. Macedo. 2004. Lung eosinophilic inflammation and airway hyperreactivity are enhanced by murine anaphylactic, but not nonanaphylactic, IgG1 antibodies. J. Allergy Clin. Immunol. 114: 97-104.
50. -/- mice abrogates the development of allergic lung inflammation. J. Immunol. 175: 1276-1285.
51. Ludviksson, B. R., G. J. Arason, O. Thorarensen, B. Ardal, and H. Valdimarsson. 2005. Allergic diseases and asthma in relation to serum immunoglobulins and salivary immunoglobulin A in pre-school children: a follow-up community-based study. Clin. Exp. Allergy 35: 64-69.
52. Brown, M. B., and L. Reyes. 1991. Immunoglobulin class- and subclass-specific responses to Mycoplasma pulmonis in sera and secretions of naturally infected Sprague-Dawley female rats. Infect. Immun. 59: 2181-2185.
53. Simecka, J. W., and G. H. Cassell. 1987. Serum antibody and cellular responses in LEW and F344 rats after immunization with Mycoplasma pulmonis antigens. Infect. Immun. 55: 731-735.
54. Robinson, D. S., and C. M. Lloyd. 2002. Asthma: T-bet-a master controller? Curr. Biol. 12: R322-R324.
55. Denzler, K. L., M. T. Horchers, J. R. Crosby, G. Cieslewicz, E. M. Hines, J. P. Justice, S. A. Cormier, K. A. Lindenberger, W. Song, W. Wu, et al. 2001. Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J. Immunol. 167: 1672-1682.
56. Kobayashi, T., K. Iijima, and H. Kita. 2003. Marked airway eosinophilia prevents development of airway hyper-responsiveness during an allergic response in IL-5 transgenic mice. J. Immunol. 170: 5756-5763.
57. Shen, H. H., S. I. Ochkur, M. P. McGarry, J. R. Crosby, E. M. Hines, M. T. Borchers, H. Wang, T. L. Biechelle, K. R. O'Neill, T. L. Ansay, et al. 2003. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies in the mouse. J. Immunol. 170: 3296-3305.
58. Chu, H. W., J. G. Rino, R. B. Wexler, K. Campbell, R. J. Harbeck, and R. J. Martin. 2005. Mycoplasma pneumoniae infection increases airway collagen deposition in a murine model of allergic airway inflammation. Am. J. Physiol. 289: L125-L133.